Treatment for patients with ENT conditions that can be safely managed in the community.

Treatment of ingested metal foreign body in children with no red flags.

This programme provides funding for IV iron infusions for patients who meet the PHARMAC special authority criteria for prescribing subsidised ferric carboxymaltose (Ferinject) in the community.

Administration of IV adenosine treatment for patients with rapid palpitations and a systolic BP >100 that can be safely managed in primary care.

Treatment of patients with acute neurological conditions that can be managed safely in primary care. e.g. migraine.

Treatment for adults and children with moderate pneumonia that can be managed safely in the community.

General practice plays a critical role in the delivery of childhood immunisations. This funding aims to alleviate some of the administrative burden currently being experienced by general practice and is part of a broader approach to support an increase in completion of 6-week immunisation rates. Please note this funding is available 1 April 2024 to 30 June 2025.

Treatment of patients with acute urological problems that can be managed safely in primary care.

Treatment of patients with a severe allergic reaction and can be safely managed in the community.

Treatment of patients with abdominal pain, who are haemodynamically stable.

Treatment of patients with suspected ACC related DVT with a Wells Score of >= 2 or a positive D-dimer.

Treatment of patients with low risk undifferentiated chest pain (within 5 days of presentation) where the diagnosis is unclear, but the patient would otherwise be sent acutely to hospital for ECG. This funding does not cover the cost of a routine ECG